Literature DB >> 1791834

Glycine 119 of bovine growth hormone is critical for growth-promoting activity.

W Y Chen1, D C Wight, B V Mehta, T E Wagner, J J Kopchick.   

Abstract

Bovine GH (bGH) analogs with single amino acid substitutions at positions 117 (bGH-E117L), 119 (bGH-G119R), and 122 (bGH-A122D) were generated. These analogs bind to mouse liver membrane preparations with affinities similar to native bGH. However, transgenic mice which express the analogs demonstrate different phenotypes ranging from dwarfism to gigantism. For example, expression of bGH or bGH-E117L result in large transgenic mice. In contrast, transgenic mice with a growth phenotype similar to nontransgenic animals result from expression of bGH-A122D. Surprisingly, transgenic mice with relatively high serum levels of bGH-G119R possessed a dwarf phenotype. Together these results suggest that Gly 119 and Ala 122 are involved in growth-promoting activity of GH.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1791834     DOI: 10.1210/mend-5-12-1845

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  33 in total

Review 1.  Recombinant analogues of prolactin, growth hormone, and placental lactogen: correlations between physical structure, binding characteristics, and activity.

Authors:  A Gertler
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

2.  Evidence for growth hormone (GH) autoregulation in pituitary somatotrophs in GH antagonist-transgenic mice and GH receptor-deficient mice.

Authors:  S L Asa; K T Coschigano; L Bellush; J J Kopchick; S Ezzat
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 3.  GH receptor antagonist: mechanism of action and clinical utility.

Authors:  Sowmya K Surya; Ariel L Barkan
Journal:  Rev Endocr Metab Disord       Date:  2005-01       Impact factor: 6.514

Review 4.  Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models.

Authors:  Darlene E Berryman; Jens Sandahl Christiansen; Gudmundur Johannsson; Michael O Thorner; John J Kopchick
Journal:  Growth Horm IGF Res       Date:  2008-08-16       Impact factor: 2.372

Review 5.  Pegvisomant: a growth hormone receptor antagonist used in the treatment of acromegaly.

Authors:  Nicholas A Tritos; Beverly M K Biller
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 6.  Altered structure and function of adipose tissue in long-lived mice with growth hormone-related mutations.

Authors:  Justin Darcy; Samuel McFadden; Andrzej Bartke
Journal:  Adipocyte       Date:  2017-03-21       Impact factor: 4.534

7.  Increased fibrosis: A novel means by which GH influences white adipose tissue function.

Authors:  Lara A Householder; Ross Comisford; Silvana Duran-Ortiz; Kevin Lee; Katie Troike; Cody Wilson; Adam Jara; Mitchell Harberson; Edward O List; John J Kopchick; Darlene E Berryman
Journal:  Growth Horm IGF Res       Date:  2017-12-20       Impact factor: 2.372

8.  Growth hormone receptor antagonist transgenic mice are protected from hyperinsulinemia and glucose intolerance despite obesity when placed on a HF diet.

Authors:  Tianxu Yang; Lara A Householder; Ellen R Lubbers; Edward O List; Katie Troike; Clare Vesel; Silvana Duran-Ortiz; John J Kopchick; Darlene E Berryman
Journal:  Endocrinology       Date:  2014-11-18       Impact factor: 4.736

9.  Crystal structure of an affinity-matured prolactin complexed to its dimerized receptor reveals the topology of hormone binding site 2.

Authors:  Isabelle Broutin; Jean-Baptiste Jomain; Estelle Tallet; Jan van Agthoven; Bertrand Raynal; Sylviane Hoos; Birthe B Kragelund; Paul A Kelly; Arnaud Ducruix; Patrick England; Vincent Goffin
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

Review 10.  The GH/IGF-1 axis in ageing and longevity.

Authors:  Riia K Junnila; John J Kopchick; Edward O List; Darlene E Berryman; John W Murrey
Journal:  Nat Rev Endocrinol       Date:  2013-04-16       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.